Delhi court permanently bars Sainus Pharma from using Udaan mark in RSPL Health case
A Delhi court found Sainus Pharma’s Udaan branding deceptively similar to RSPL Health’s registered Udan sanitary-napkin trademark. Counterfeit products and infringing packaging seized in the case must be handed to RSPL for destruction.
What happened
RSPL Health Private Limited · A Delhi court permanently barred Hyderabad-based Sainus Pharma from using the Udaan trademark, finding it deceptively similar to
Key facts
- 2007
- Aug. 13
Why this matters
For acquirers and partners, the case highlights the value of trademark diligence and enforceable brand rights when evaluating consumer-health assets.
What to watch
- New RSPL cease-and-desist actions, raids or court filings involving similar feminine-hygiene marks.
- Marketplace delistings and distributor recalls of Sainus Pharma products.
- A Sainus Pharma appeal, rebranding announcement or launch of replacement packaging.
- RSPL marketing, trade promotions or distribution expansion for Udan in southern and value-focused markets.
- Evidence of counterfeit Udan products resurfacing under altered labels or through online sellers.
- RSPL is likely to issue distributor and marketplace notices requiring removal of Udaan-branded inventory and listings.
- RSPL may intensify trademark surveillance across feminine-hygiene packaging, pharmacy wholesalers and regional e-commerce sellers.
- Sainus Pharma may rebrand, seek to clear remaining inventory without the disputed mark, or challenge implementation details while complying with the injunction.
- Competitors may review naming and packaging for phonetic similarity risk, especially around low-cost sanitary-napkin brands.